Atrius Health Central OB/GYN CME Presents: OB/GYN February 2026 CME/CNE, 02/04/2026

Claiming Credit for Session
Thank you for attending Atrius Health's OB/GYN meeting on February 4, 2026. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to take an evaluation to claim your credit on the following page.

Educational Needs Addressed

In this meeting, presenters will discuss advances in guidelines and treatments as identified by Atrius internal specialists, our QA committee and our CME planning committee.  Our goal is to improve patient care and support our clinicians.

Target Audience

Atrius Health OB/GYN Clinicians

Learning Objectives

At the completion of this activity, participants will be better able to:

  • Review OBGYN-related practice and personnel updates, CME/CEU resources for credits
  • Describe leadership updates on goals for the specialty
  • Improve the quality and safety of our patient care by learning from past performance and identify and suggest practice and systems improvements to prevent similar future episodes
  • Provide updates to ACOG-endorses clinical guidelines
  • Describe guidelines for Referral to Special Procedure Unit (SPU)
  • Discuss rapidly changing treatments and guidelines for menopause carConsider variable referral and treatment for vulvovaginal disease
  • Select options for Vaginitis and Bacterial Vaginosis (BV) treatment and partner treatment
Course summary
Available credit: 
  • 3.50 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 3.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 3.50 MA Risk Management
  • 3.50 ANCC
    • 1.00 ANCC Pharmacology
  • 3.50 Participation
Course opens: 
02/04/2026
Course expires: 
03/04/2026
Rating: 
0

Accreditor Disclosure Policy
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.

Faculty Presenters and Disclosures
Christopher Morrison, MD
Course Director
Obstetrics and Gynecology
Atrius Health

Drs. Diaz, Richardson, Morrison, Hale, Wolfe, have no relevant financial relationships to disclose.

Dr. Carolin Mitchell has been a consultant for Freya Biosciences, Diva Inc and GSK and serves on the scientific advisory board of Ancilia Biosciences and Concerto Biosciences. CMM has a financial interest in Ancilia Biosciences, a company developing a new class of Live Biotherapeutics and other bacterial products. Dr. Mitchell’s interests were reviewed and are managed by MGH and Mass General Brigham in accordance with their conflict-of-interest policies

Off-label Discussion: some of the molecular dx tests and treatment options discussed in the Vaginitis presentation are not FDA approved

Planning Committee

Drs. Li, Morrison, Platek, Richardson, Staudenmaier and Ms. Caitlyn Mayhew have no relevant financial relationships to disclose. Meghan Bride, NP planning committee member, is a trainer for Organon/Merck. 

Accreditor Disclosures
The following planning committee members from Boston University Chobanian & Avedisian School of Medicine’s Center for Continuing Education have no relevant financial relationships: Michael Burk, BS, Operations Manager; Daniel Alford, MD, Assistant Dean.

Disclaimer
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS.  ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE.  TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS.  IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS.  IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.  IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

 

 

 

In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and Atrius Health. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 

 

Physician AMA PRA Category 1 Credit™ 
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Risk Management
This program includes 3.5 hours which meet the criteria of the Massachusetts Board of Registration in Medicine for risk management study.

Nursing Accreditation
Contact Hours: 3.5, of which 1.0 are eligible for pharmacology credit.

Interprofessional Continuing Education Credit
This activity was planned by and for the healthcare team, and learners will receive 3.5 Interprofessional Continuing Education (IPCE) credits for learning and change.
 

Available Credit

  • 3.50 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 3.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 3.50 MA Risk Management
  • 3.50 ANCC
    • 1.00 ANCC Pharmacology
  • 3.50 Participation
Please login or register to take this course.